• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Verdi Mark A was granted 4,825 shares, increasing direct ownership by 8% to 65,005 units (SEC Form 4)

    5/27/25 4:59:49 PM ET
    $G
    Professional Services
    Consumer Discretionary
    Get the next $G alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Verdi Mark A

    (Last) (First) (Middle)
    C/O GENPACT LLC
    521 FIFTH AVENUE, 14TH FLOOR

    (Street)
    NEW YORK NY 10175

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Genpact LTD [ G ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/22/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Shares 05/22/2025 A 4,825(1) A $0 65,005 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.
    Remarks:
    /s/ Thomas D. Scholtes, as Attorney-in-fact for Mark Verdi 05/27/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $G alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $G

    DatePrice TargetRatingAnalyst
    2/7/2025$45.00 → $60.00Hold → Buy
    TD Cowen
    1/21/2025$44.00 → $55.00Hold → Buy
    Jefferies
    7/17/2024$43.00 → $40.00Underweight → Neutral
    JP Morgan
    1/30/2024$40.00Neutral
    Mizuho
    12/15/2023$38.00Outperform → Neutral
    Robert W. Baird
    8/22/2023$40.00Neutral → Underweight
    JP Morgan
    7/18/2023$46.00 → $42.00Buy → Neutral
    Citigroup
    12/15/2022$55.00 → $50.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $G
    SEC Filings

    See more
    • Genpact Limited filed SEC Form 8-K: Leadership Update

      8-K - Genpact LTD (0001398659) (Filer)

      7/1/25 4:42:02 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Limited filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Genpact LTD (0001398659) (Filer)

      5/28/25 4:27:07 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Genpact Limited

      10-Q - Genpact LTD (0001398659) (Filer)

      5/12/25 2:48:08 PM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Conigliaro Laura was granted 4,825 shares, increasing direct ownership by 7% to 72,816 units (SEC Form 4)

      4 - Genpact LTD (0001398659) (Issuer)

      5/27/25 5:01:19 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Director Gangestad Nicholas C was granted 4,825 shares, increasing direct ownership by 241% to 6,825 units (SEC Form 4)

      4 - Genpact LTD (0001398659) (Issuer)

      5/27/25 5:01:08 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Director Franklin Tamara was granted 4,825 shares, increasing direct ownership by 24% to 24,986 units (SEC Form 4)

      4 - Genpact LTD (0001398659) (Issuer)

      5/27/25 5:00:55 PM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genpact Appoints John M. Hinshaw to Board of Directors

      NEW YORK, July 1, 2025 /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company, today announced that John M. Hinshaw has been appointed to the Company's Board of Directors, effective July 1, 2025. "We welcome John to Genpact's Board of Directors," said Balkrishan "BK" Kalra, President and CEO, Genpact. "John's extensive expertise in managing change and evolution at some of the world's largest and most recognizable brands will be a tremendous asset as we help clients leverage AI and agentic innovations to drive their businesses forward." Most rec

      7/1/25 8:05:00 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Recognized as One of the World's Most Sustainable Companies by TIME and Statista

      Recognition reflects Genpact's culture of empowering its workforce to foster innovation, deliver client impact, and help build a more sustainable future NEW YORK, June 30, 2025 /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company, today announced its inclusion in the TIME World's Best Companies in Sustainable Growth 2025 list. This recognition highlights Genpact's strong financial performance and deep commitment to sustainable business practices, all driven by its exceptional global talent. To compile this list, TIME and Statista evaluated 5

      6/30/25 8:05:00 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Unveils GenpactNext Framework and Outlines Medium-Term Targets at 2025 Investor Day

      NEW YORK, June 26, 2025 /PRNewswire/ -- Genpact (NYSE:G) will host an Investor Day in New York and online today, beginning at 1:00 PM ET. Members of Genpact's senior leadership team will provide an in-depth view of the Company's growth model and strategic framework for its pivot to AI and other advanced technologies. Genpact will also share medium-term financial targets, as well as an update on second quarter and full year 2025. "This is our pivotal moment as we lead Genpact into its next chapter - to focus and grow as an AI-first, data-led innovation company," said Balkrishan

      6/26/25 8:05:00 AM ET
      $G
      Professional Services
      Consumer Discretionary

    $G
    Leadership Updates

    Live Leadership Updates

    See more
    • Genpact Appoints John M. Hinshaw to Board of Directors

      NEW YORK, July 1, 2025 /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company, today announced that John M. Hinshaw has been appointed to the Company's Board of Directors, effective July 1, 2025. "We welcome John to Genpact's Board of Directors," said Balkrishan "BK" Kalra, President and CEO, Genpact. "John's extensive expertise in managing change and evolution at some of the world's largest and most recognizable brands will be a tremendous asset as we help clients leverage AI and agentic innovations to drive their businesses forward." Most rec

      7/1/25 8:05:00 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Announces Chief Strategy and Corporate Development Officer

      Strategic business development leader Jinsook Han joins Genpact to spearhead strategy and M&A NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Jinsook Han has joined the Company as Chief Strategy and Corporate Development Officer, effective immediately. She will be responsible for the company's strategy and investments, including ventures and acquisitions. Jinsook will report to President and CEO, Balkrishan "BK" Kalra. "Jinsook has that rare profile that

      11/12/24 4:05:00 PM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact Appoints Sanjeev Vohra as First Chief Technology & Innovation Officer

      Seasoned technologist joins Genpact to accelerate AI and advanced technology roadmaps NEW YORK, Aug. 7, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Sanjeev Vohra has been named as the Company's first Chief Technology & Innovation Officer, effective immediately. Vohra will report to President and CEO, Balkrishan "BK" Kalra. Vohra, a seasoned leader and respected innovator, brings more than 30 years of technology, consulting and industry expertise to Genpact. His appointm

      8/7/24 8:16:00 AM ET
      $G
      Professional Services
      Consumer Discretionary